Molecular Biomarkers & Diagnosis

The Role of Exosome-Based Biomarkers in Chronic Inflammatory Disease Diagnosis

Abstract

Rafael Costa*

Chronic Inflammatory Diseases (CIDs), including rheumatoid arthritis, inflammatory bowel disease, and chronic obstructive pulmonary disease, are a major global health concern due to their high prevalence, complex etiology, and associated morbidity. Early diagnosis and accurate monitoring of disease progression are essential for effective treatment and improved patient outcomes. In recent years, exosome-based biomarkers have garnered significant attention as a promising tool for diagnosing and monitoring chronic inflammatory diseases. Exosomes, small extracellular vesicles secreted by various cell types, contain bioactive molecules such as proteins, lipids, and RNA, which can reflect the molecular alterations occurring in the body during disease processes.